Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

New findings provide compelling evidence for the protective benefits of maternal RSVpreF vaccination during pregnancy.

The number of COVID-19 infections in China has been steadily rising since early April, but the overall spread of acute ...

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.

The Kids Research Institute Australia’s latest strategy signals a pivotal shift, not just in what it aims to achieve, but how ...

In documents requesting the order, Bailey alleges that there have been “multiple acts of physical violence” following their ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue ...

DDG responded to Bailey's claims violently, screaming profanities at her, damaging her ring camera, and attempting to take their child with him without her consent. Halle's request for a restraining ...

The charity provided her and her former partner, Joe, with a place to stay while their son, Jaxxon, was critically ill.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to require all new vaccines be tested against a placebo ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...

Recent findings of the impact of new RSV prevention products aimed at protecting babies were published in the Morbidity and Mortality Weekly Report, an epidemiological digest prepared by the Centers ...